title: Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia.
authors.forename: Yoji
authors.initials: Y
authors.lastname: Nagasaki
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Miyamoto
authors.forename: Hideho
authors.initials: H
authors.lastname: Henzan
authors.forename: Koji
authors.initials: K
authors.lastname: Nagafuji
authors.forename: Mine
authors.initials: M
authors.lastname: Harada
authors.forename: Koichi
authors.initials: K
authors.lastname: Akashi
mesh_terms: D000328:Adult; D001549:Benzamides; D004351:Drug Resistance; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011239:Prednisolone